Loading

Treatment Options for Ménière's Disease

There's no cure for Ménière's disease, but you can manage its symptoms. Diet and medication help some people. If that doesn't work, Meniett therapy is the next level of Ménière's disease treatment that is safe, simple, and effective.1-12 It may help your dizziness and vertigo so you can avoid more invasive surgery.

Ménière’s disease is different in each patient and unpredictable. For some, Ménière’s disease improves with or without treatment.13 For others, symptoms progressively worsen. That’s why doctors often follow the Ménière's disease treatment ladder. This means trying low risk treatments for Ménière's disease before serious surgery.

Ménière’s disease treatment ladder 

Detail – Ménière's disease is different in each patient, so doctors often follow the treatment ladder and start with lower risk treatments first

Many Ménière's disease treatments try to reduce the fluid in the inner ear. Doctors believe that excess fluid and swelling in this area causes Ménière's disease symptoms.13-17

Diet/Lifestyle Changes and Medical Therapy

This is a first-level treatment for Ménière's disease. It often includes a low-salt diet, diuretics (“water pills”), stress management, and medications to help your Ménière's disease.13-14
Learn More

Meniett Therapy

This second-level treatment is a safe, simple, and effective way to manage Ménière’s disease dizziness and vertigo.1-12 It delivers micropressure therapy and is based on nearly 30 years of clinical research.1-12,18-21
Learn More

Surgical or Destructive Therapy

Surgery is considered a third-level treatment for Ménière's disease. It’s usually only tried after less risky Ménière’s disease therapies have failed to help. Surgical or destructive Ménière’s disease treatments include:

  • Draining fluid from the inner ear
  • Cutting the balance nerve
  • Removing some or all of the inner ear
  • Ear injections that reduce or destroy inner ear function

Learn More

Ménière’s Disease Resources

Here are some resources for living with Ménière’s disease.
Learn More

If you have questions about Ménière’s disease or any Ménière’s disease treatment, be sure to ask your ear, nose, and throat (ENT) or ear specialist.

References

View full listView full list

  1. Dornhoffer JL, King D. The effect of the Meniett device in patients with Ménière's disease: long-term results. Otol Neurotol 2008; 29(6):868-74.
  2. Mattox DE, Reichert M. Meniett device for Ménière's disease: use and compliance at 3 to 5 years. Otol Neurotol 2008; 29(1):29-32.
  3. Weining H, Fang L, Bo G, Jinmei Z. Clinical long-term effects of Meniett pulse generator for Ménière's disease. Acta Otolaryngol 2009; 129(8):819-825.
  4. Barbara M, Maurizio Monini S, Chiappini I, Filipo R. Meniett therapy may avoid vestibular neurectomy in disabling Ménière's disease. Acta Otolaryngol 2007; 127(11):1136-1141.
  5. Nabi S, Parnes LS. Bilateral Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg 2009; 17:356-362.
  6. Thomsen J, Sass K, Ödkvist L, Arlinger S. Local over-pressure treatment reduces vestibular symptoms in patients with Ménière’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005; 26:68-73.
  7. Rajan GP, Din S, Atlas MD. Long-term effects of the Meniett device in Ménière’s disease: the Western Australian experience. J Laryngol Otol 2005; 119:391-395.
  8. Densert B, Sass K. Control of symptoms in patients with Ménière’s disease using middle ear applications: A two-year follow-up. Acta Otolaryngol 2001; 121(5):616-621.
  9. Gates GA, Green Jr. JD, Tucci DL, Telian SA. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch of Oto – HNS 2004; 130(6):718-725.
  10. Gates GA, Verrall A, Green Jr. JD, Tucci DL, Telian SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006; 132:1311-1316.
  11. Ödkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallquist J. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière’s disease: A clinical, multicenter, placebo-controlled study. Acta Otolaryngol Suppl 2000; 543: 99-101.
  12. Densert B, Densert O, Arlinger S, Sass K, Ödkvist LM. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Ménière’s disease: A clinical placebo-controlled study. 1997; Am J Otol 18:726-733.
  13. Torok N. Old and new in Ménière’s disease. Laryngoscope. 1977; 87(11):1870-1877.
  14. Schuknecht HF. Pathophysiology of Ménière’s disease. Otolaryngol Clin North Am 1975; 8(2):507-514.
  15. Gulya AJ. Schuknecht HF. Classification of endolymphatic hydrops. Am J Otolaryngol 1982; 3(5):319-322.
  16. Claes J, Van de Heyning PH. Medical treatment of Ménière’s disease: A review of literature. Acta Otolaryngol Suppl 1977; 526:10-13.
  17. Furstenberg AC, Lashmet FH, Lathrop FD. Ménière’s symptom complex: medical treatment. Ann Otol Rhinol Laryngol 1934; 43:1035-1047.
  18. Densert B, Densert O. Overpressure in treatment of Ménière’s disease. Laryngoscope 1982; 92:1285-1292.
  19. Densert B. Effects of overpressure on hearing function in Ménière’s disease. Acta Otolaryngol (Stockh) 1987; 103:32-42.
  20. Feijen RA, Segenhout JM, Wit HP, Albers FWJ. Monitoring inner ear pressure changes in normal guinea pigs induced by the Meniett 20. Acta Otolaryngol 2000; 804-809.
  21. Densert B, Sass K, Arlinger S. Short-term effects of induced middle ear pressure changes on the electrocochleogram in Ménière’s disease. Acta Otolaryngol (Stockh) 1995; 115: 732-737.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 19 Jul 2011

Section Navigation

Additional information

Contact Us

Customer Service
Medtronic
work (877) 966-3350 phone
work (866) 463-8726 fax